tradingkey.logo
tradingkey.logo
Search

Addus HomeCare Q1 adjusted EPS rises

ReutersMay 4, 2026 8:22 PM
facebooktwitterlinkedin
View all comments0


Overview

  • U.S. home care provider's Q1 revenue rose 7.7% yr/yr

  • Adjusted EPS for Q1 rose 14.1% and beat analyst expectations

  • Company acquired Indiana-based HomeCourt Home Care and agreed to buy another Indiana operation


Outlook

  • Company expects continued organic growth and additional value from acquired operations in 2026

  • Addus anticipates further acquisition opportunities and expansion in 2026

  • Company sees favorable business trends and ongoing demand for home-based care services


Result Drivers

  • PERSONAL CARE GROWTH - Organic revenue in personal care rose 6.5%, driven by higher service volumes and rate increases in Texas and Illinois

  • HOSPICE SEGMENT - Hospice business delivered 7.7% organic revenue growth, supported by a higher average daily census

  • STABLE HIRING - Company reported stable and consistent hiring trends despite brief winter weather interruptions in January


Company press release: ID:nBwb6HlvQa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Adjusted EPS

Beat

$1.62

$1.55 (14 Analysts)

Q1 Adjusted Net Income

Beat

$30 mln

$28.84 mln (11 Analysts)

Q1 Net Income

$25.10 mln

Q1 Adjusted EBITDA

Slight Beat*

$44.50 mln

$44.39 mln (13 Analysts)

Q1 Operating Cash Flow

$52.40 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Addus Homecare Corp is $140.00, about 40.6% above its May 1 closing price of $99.56

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 15 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI